Day 27 🧪 Welcome back to 30 Days of ASCP: Ratchet Study Tips 🤪🤏🏽🤏🏽🤏🏽 Today we’re breaking down Hodgkin vs Non-Hodgkin lymphoma so you stop second-guessing yourself. Hodgkin lymphoma is defined by the presence of Reed-Sternberg cells and typically spreads in an orderly, contiguous patternfrom one lymph node group to the next, often with a strong association with EBV. Non-Hodgkin lymphoma is much more variable: multiple subtypes, wider age range, frequent extranodal involvement, and no pre

Welcome back to 30 Days of ASCP: Make It Make Sense Series, because once you get it, you never forget it. Day 1/30: Today is World AIDS Day, so let’s break down how someone is actually diagnosed with AIDS from the laboratory perspective. A person is first screened for HIV using a 4th-generation antigen/antibody test, which detects HIV-1, HIV-2, and the p24 antigen. If that test is positive, we move to an HIV-1/HIV-2 differentiation assay to determine which virus is present. If that result comes

Day 9 🧪 Welcome back to 30 Days of ASCP: Make It Make Sense, because once you get it, you never forget it. Elution and adsorption are both used to separate antibodies from red blood cells, but they serve different purposes. Elution is used when an antibody is already attached to the patient’s red cells; we strip it off to identify what that antibody is, which is especially important in cases like positive DATs or hemolytic disease of the newborn. Adsorption is used when antibodies are free in t

🚨📢 ASCP Exam Coming Up? STOP Scrolling! If you are stressed, overwhelmed, or just don't know where to start - I got you. I created the ULTIMATE ASCP Exam Prep E-Book that breaks everything down in a way that actually makes sense (and sticks). Whether you are struggling with blood bank, microbiology or chemistry - this is for YOU! But here's what makes this different 👇 My Skool Community is full of motivated CLS/MLS Students just like you. We are talking: ✅️ Weekly Study Sessions With ME! ✅️ H

8.8K views · 557 reactions | Want to PASS the ASCP exam? Here’s the...